🇺🇸 FDA
Patent

US 7576053

Methods and compositions for treating degenerative bone disorders

granted A61KA61K31/202A61K31/506

Quick answer

US patent 7576053 (Methods and compositions for treating degenerative bone disorders) held by Rigel Pharmaceuticals, Inc. expires Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Rigel Pharmaceuticals, Inc.
Grant date
Tue Aug 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
31
CPC classes
A61K, A61K31/202, A61K31/506, A61K31/5383, A61K31/56